People: Jiangsu Kanion Pharmaceutical Co Ltd (600557.SS)
600557.SS on Shanghai Stock Exchange
26.38CNY
2:59am EDT
26.38CNY
2:59am EDT
Price Change (% chg)
¥-0.79 (-2.91%)
¥-0.79 (-2.91%)
Prev Close
¥27.01
¥27.01
Open
¥26.98
¥26.98
Day's High
¥27.29
¥27.29
Day's Low
¥26.36
¥26.36
Volume
3,286,846
3,286,846
Avg. Vol
5,086,999
5,086,999
52-wk High
¥32.40
¥32.40
52-wk Low
¥13.75
¥13.75
Summary
| Name | Age | Since | Current Position |
|---|---|---|---|
Wei Xiao |
54 | 2008 | Chairman of the Board, General Manager, Chief Engineer |
Yin Yang |
51 | 2007 | Vice Chairman of the Board |
Youlong Chen |
38 | 2007 | Chief Financial Officer |
Yongchun Yang |
40 | 2008 | Chief Marketing Officer, Deputy General Manager |
Ya Ling |
53 | 2010 | Executive Deputy General Manager, Director |
Chuanbao Guo |
39 | 2010 | Executive Deputy General Manager |
Wusheng Liu |
37 | 2011 | Deputy General Manager |
Zhenzhong Wang |
45 | 2010 | Deputy General Manager |
Fan Cheng |
45 | 2006 | Secretary of the Board |
Yue Xia |
42 | 2010 | Director |
Yunbin Gao |
46 | 2007 | Independent Director |
Dequan Ren |
68 | 2007 | Independent Director |
Boli Zhang |
65 | 2007 | Independent Director |
Biographies
| Name | Description |
|---|---|
Wei Xiao |
Mr. Xiao Wei has been Chairman of the Board, General Manager and Chief Engineer in Jiangsu Kanion Pharmaceutical Co., Ltd. since October 16, 2008. He is also Chairman of the Board in Jiangsu Kanion Group, Ltd. He holds a Ph.D. in Traditional Chinese Medicine. |
Yin Yang |
Mr. Yang Yin has been Vice Chairman of the Board in Jiangsu Kanion Pharmaceutical Co., Ltd. since April 17, 2007. He is also serving as Vice Chairman of the Board and General Manager in Jiangsu Kanion Group, Ltd., He used to serve as General Manager in the Company from December 2000 to April 2007. He holds a Master of Business Administration (MBA). |
Youlong Chen |
Mr. Chen Youlong has been Chief Financial Officer in Jiangsu Kanion Pharmaceutical Co., Ltd. since April 17, 2007. He used to serve as Finance Manager in two other companies. |
Yongchun Yang |
Mr. Yang Yongchun has been Deputy General Manager and Chief Marketing Officer in Jiangsu Kanion Pharmaceutical Co., Ltd. He was Manager of Branch and Manager of Marketing and Finance in the Company. He is also Chairman of the Board in another pharmaceutical company. |
Ya Ling |
Ms. Ling Ya has been Executive Deputy General Manager and Director in Jiangsu Kanion Pharmaceutical Co., Ltd. since August 9, 2010. She used to serve as Deputy General Manager and Assistant General Manager in the Company. She is also Director in Jiangsu Kanion Group, Ltd. |
Chuanbao Guo |
Mr. Guo Chuanbao has been Executive Deputy General Manager in Jiangsu Kanion Pharmaceutical Co., Ltd. He used to serve as Deputy General Manager, Chief Marketing Officer, Assistant General Manager and Manager of Branch in the Company. |
Wusheng Liu |
Mr. Liu Wusheng is Deputy General Manager in Jiangsu Kanion Pharmaceutical Co., Ltd. He holds a Master of Business Administration. |
Zhenzhong Wang |
Mr. Wang Zhenzhong has been Deputy General Manager since March 25, 2010 in Jiangsu Kanion Pharmaceutical Co., Ltd. He used to Director of Research and Development and Deputy Head-Research & Development Center of the Company. |
Fan Cheng |
Mr. Cheng Fan has been Secretary of the Board in Jiangsu Kanion Pharmaceutical Co., Ltd. He was Deputy General Manager in the Company. He is also Director in Lianyungang Kanion Group, Ltd. He holds a Master of Business Administration (MBA). |
Yue Xia |
Mr. Xia Yue has been Director in Jiangsu Kanion Pharmaceutical Co., Ltd. He was Deputy General Manager in the Company. He is also Director in Jiangsu Kanion Group, Ltd., as well as Chairman of the Board in a Jiangsu-based medical company. He holds a Master of Business Administration (MBA). |
Yunbin Gao |
Mr. Gao Yunbin has been Independent Director in Jiangsu Kanion Pharmaceutical Co., Ltd. since April 17, 2007. He is also Chairman of the Board in a Jiangsu-based tax consultancy company. He is a Certified Public Accountant, Certified Tax Agent as well as a Certified Public Valuer. |
Dequan Ren |
|
Boli Zhang |
Mr. Zhang Boli has been Independent Director in Jiangsu Kanion Pharmaceutical Co., Ltd. since April 17, 2007. He is Professor of Tianjin University of Traditional Chinese Medicine, China. |
Basic Compensation
| Name | Fiscal Year Total |
|---|---|
Wei Xiao |
908,100 |
Yin Yang |
768,000 |
Youlong Chen |
315,100 |
Yongchun Yang |
514,500 |
Ya Ling |
554,500 |
Chuanbao Guo |
557,200 |
Wusheng Liu |
538,800 |
Zhenzhong Wang |
525,400 |
Fan Cheng |
482,500 |
Yue Xia |
203,400 |
Yunbin Gao |
40,000 |
Dequan Ren |
40,000 |
Boli Zhang |
40,000 |
As Of 30 Dec 2012
Options Compensation
| Name | Options | Value |
|---|---|---|
Wei Xiao |
0 | 0 |
Yin Yang |
0 | 0 |
Youlong Chen |
0 | 0 |
Yongchun Yang |
0 | 0 |
Ya Ling |
0 | 0 |
Chuanbao Guo |
0 | 0 |
Wusheng Liu |
0 | 0 |
Zhenzhong Wang |
0 | 0 |
Fan Cheng |
0 | 0 |
Yue Xia |
0 | 0 |
Yunbin Gao |
0 | 0 |
Dequan Ren |
0 | 0 |
Boli Zhang |
0 | 0 |
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
